Skip to main content

ADVERTISEMENT

DFU

Standard treatment of chronic diabetic foot ulcers (DFU) is expensive and, for more than half of DFU patients, unsuccessful1. Health care policy decision makers should seek the most effec...
08/19/2021
Purpose: Poloxamer 188* (P188) is a concentrated water-soluble hydrogel and surfactant used in the treatment of diabetic foot ulcerations. Hydrogels maintain moist environments while prom...
08/19/2021
Problem:  Diabetic foot ulceration (DFU) is a complication of diabetes that can lead to infection and/or amputation. DFU occurs in roughly 15 to 25% of patients with diabetes1. Recurrence...
08/19/2021
Introduction: Diabetic foot ulcers (DFUs) are an unfortunately common and grave complication of diabetes mellitus with up to 34% of people with diabetes potentially developing lower extr...
08/19/2021
We present the first prospective multicenter randomized controlled trial evaluating the effects of Omega3 rich fish skin* for treatment of diabetic foot ulcers.
08/19/2021
Introduction: Diabetic foot ulcers (DFUs) are a significant burden on the worldwide health-care system. These chronic lower extremity wounds are often refractory to standard of care and c...
11/04/2019
Introduction: Advanced tissue matrices have shown promise for treating diabetic wounds and other soft tissue defects. Recent advancements in technology have led to the introduction of a n...
11/04/2019
Background: The traditional Total Contact Cast (tTCC) has been used as the gold standard for treating diabetic foot ulcers (DFU). The application of tTCC is time consuming and requir...
08/19/2019
Objective: Targeted, appropriate antimicrobials can prevent escalation to infection and future antibiotic necessity. Antimicrobial misuse often stems from diagnostic uncertainty duri...
08/19/2019
Objective: The clinical evaluation of signs and symptoms (CSS) to determine a wound’s bacterial load and infection status is paramount to wound assessment.
08/19/2019